HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LASSBio-788

a vasodilator agent; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - Hydrazones: 500
    - LASSBio-788: 2
- Sulfur Compounds: 278
  - Thiophenes: 257
    - LASSBio-788: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Thiophenes: 257
    - LASSBio-788: 2

Experts

1.	Barreiro, Eliezer Jesus: 1 article (09/2013)
2.	Dos Santos, Caroline Fernandes: 1 article (09/2013)
3.	Fraga, Carlos Alberto Manssour: 1 article (09/2013)
4.	Kümmerle, Arthur Eugen: 1 article (09/2013)
5.	Marostica, Elisabeth: 1 article (09/2013)
6.	da Motta, Nadia Alice Vieira: 1 article (09/2013)
7.	de Brito, Fernanda Carla Ferreira: 1 article (09/2013)
8.	de Miranda, Ana Luisa Palhares: 1 article (09/2013)
9.	Barreiro, Eliezer J: 1 article (05/2005)
10.	Fraga, Carlos A M: 1 article (05/2005)

Related Diseases

1.	Atherosclerosis 09/20/2013 - "Our results suggest that the compound LASSBio-788 represents a new multi-targeted drug candidate for the treatment of atherosclerosis. " 09/20/2013 - "We hypothesize that LASSBio-788 may exert beneficial effects on atherosclerosis. "
2.	Contracture 05/16/2005 - "Phenylephrine-induced contracture in the aorta was inhibited by the derivatives LASSBio-785 and LASSBio-788. "

Related Drugs and Biologics

1.	Phenylephrine (Neo-Synephrine)
2.	LASSBio-785